aluates Reports

$ 0.0

Automative

Global Gastric Carcinomas Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-29K5705

Global Gastric Carcinomas Drugs Market Insights Forecast to 2028

BUY CHAPTERS

Global Gastric Carcinomas Drugs Market Research Report 2025

Code: QYRE-Auto-29K5705

Report

July 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Novo Nordisk

Bayer

Merck

Roche

Eli Lilly and Company

Taiho Pharmaceutical

Jiangsu Hengrui Medicine Company Limited

Fujian Haiwang Fuyao Pharmacy Limited Company

Qilu Pharma

Shandong New Era Hotel Pharmaceutical Industry Limited Company

Chiatai Tianqing

Gastric Carcinomas Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gastric Carcinomas Drugs Market

The global market for Gastric Carcinomas Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Gastric Carcinomas is a cancer of the gastric mucosa. Early symptoms include heartburn, upper abdominal pain, nausea, and loss of appetite. Symptoms are similar to those of peptic ulcers, leading to delayed treatment and a high mortality rate.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gastric Carcinomas Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastric Carcinomas Drugs.

The Gastric Carcinomas Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gastric Carcinomas Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gastric Carcinomas Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gastric Carcinomas Drugs Market Report

Report Metric	Details
Report Name	Gastric Carcinomas Drugs Market
CAGR	5%
Segment by Type	First Line Treatment Second Line Treatment Three Line Treatment
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novo Nordisk, Bayer, Merck & Co, Roche, Eli Lilly and Company, Taiho Pharmaceutical, Jiangsu Hengrui Medicine Company Limited, Fujian Haiwang Fuyao Pharmacy Limited Company, Qilu Pharma, Shandong New Era Hotel Pharmaceutical Industry Limited Company, Chiatai Tianqing
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gastric Carcinomas Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gastric Carcinomas Drugs Market report?

Ans: The main players in the Gastric Carcinomas Drugs Market are Pfizer, Novo Nordisk, Bayer, Merck & Co, Roche, Eli Lilly and Company, Taiho Pharmaceutical, Jiangsu Hengrui Medicine Company Limited, Fujian Haiwang Fuyao Pharmacy Limited Company, Qilu Pharma, Shandong New Era Hotel Pharmaceutical Industry Limited Company, Chiatai Tianqing

What are the Application segmentation covered in the Gastric Carcinomas Drugs Market report?

Ans: The Applications covered in the Gastric Carcinomas Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Gastric Carcinomas Drugs Market report?

Ans: The Types covered in the Gastric Carcinomas Drugs Market report are First Line Treatment, Second Line Treatment, Three Line Treatment

Recommended Reports

Gastric and Gastrointestinal Cancer

Cancer Drug Therapeutics

Cancer Diagnostics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gastric Carcinomas Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 First Line Treatment

1.2.3 Second Line Treatment

1.2.4 Three Line Treatment

1.3 Market by Application

1.3.1 Global Gastric Carcinomas Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gastric Carcinomas Drugs Market Perspective (2020-2031)

2.2 Global Gastric Carcinomas Drugs Growth Trends by Region

2.2.1 Global Gastric Carcinomas Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gastric Carcinomas Drugs Historic Market Size by Region (2020-2025)

2.2.3 Gastric Carcinomas Drugs Forecasted Market Size by Region (2026-2031)

2.3 Gastric Carcinomas Drugs Market Dynamics

2.3.1 Gastric Carcinomas Drugs Industry Trends

2.3.2 Gastric Carcinomas Drugs Market Drivers

2.3.3 Gastric Carcinomas Drugs Market Challenges

2.3.4 Gastric Carcinomas Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gastric Carcinomas Drugs Players by Revenue

3.1.1 Global Top Gastric Carcinomas Drugs Players by Revenue (2020-2025)

3.1.2 Global Gastric Carcinomas Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Gastric Carcinomas Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gastric Carcinomas Drugs Revenue

3.4 Global Gastric Carcinomas Drugs Market Concentration Ratio

3.4.1 Global Gastric Carcinomas Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gastric Carcinomas Drugs Revenue in 2024

3.5 Global Key Players of Gastric Carcinomas Drugs Head office and Area Served

3.6 Global Key Players of Gastric Carcinomas Drugs, Product and Application

3.7 Global Key Players of Gastric Carcinomas Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gastric Carcinomas Drugs Breakdown Data by Type

4.1 Global Gastric Carcinomas Drugs Historic Market Size by Type (2020-2025)

4.2 Global Gastric Carcinomas Drugs Forecasted Market Size by Type (2026-2031)

5 Gastric Carcinomas Drugs Breakdown Data by Application

5.1 Global Gastric Carcinomas Drugs Historic Market Size by Application (2020-2025)

5.2 Global Gastric Carcinomas Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gastric Carcinomas Drugs Market Size (2020-2031)

6.2 North America Gastric Carcinomas Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gastric Carcinomas Drugs Market Size by Country (2020-2025)

6.4 North America Gastric Carcinomas Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gastric Carcinomas Drugs Market Size (2020-2031)

7.2 Europe Gastric Carcinomas Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gastric Carcinomas Drugs Market Size by Country (2020-2025)

7.4 Europe Gastric Carcinomas Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gastric Carcinomas Drugs Market Size (2020-2031)

8.2 Asia-Pacific Gastric Carcinomas Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gastric Carcinomas Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Gastric Carcinomas Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gastric Carcinomas Drugs Market Size (2020-2031)

9.2 Latin America Gastric Carcinomas Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gastric Carcinomas Drugs Market Size by Country (2020-2025)

9.4 Latin America Gastric Carcinomas Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gastric Carcinomas Drugs Market Size (2020-2031)

10.2 Middle East & Africa Gastric Carcinomas Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gastric Carcinomas Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Gastric Carcinomas Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Gastric Carcinomas Drugs Introduction

11.1.4 Pfizer Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Details

11.2.2 Novo Nordisk Business Overview

11.2.3 Novo Nordisk Gastric Carcinomas Drugs Introduction

11.2.4 Novo Nordisk Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.2.5 Novo Nordisk Recent Development

11.3 Bayer

11.3.1 Bayer Company Details

11.3.2 Bayer Business Overview

11.3.3 Bayer Gastric Carcinomas Drugs Introduction

11.3.4 Bayer Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.3.5 Bayer Recent Development

11.4 Merck & Co

11.4.1 Merck & Co Company Details

11.4.2 Merck & Co Business Overview

11.4.3 Merck & Co Gastric Carcinomas Drugs Introduction

11.4.4 Merck & Co Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.4.5 Merck & Co Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Gastric Carcinomas Drugs Introduction

11.5.4 Roche Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Eli Lilly and Company

11.6.1 Eli Lilly and Company Company Details

11.6.2 Eli Lilly and Company Business Overview

11.6.3 Eli Lilly and Company Gastric Carcinomas Drugs Introduction

11.6.4 Eli Lilly and Company Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.6.5 Eli Lilly and Company Recent Development

11.7 Taiho Pharmaceutical

11.7.1 Taiho Pharmaceutical Company Details

11.7.2 Taiho Pharmaceutical Business Overview

11.7.3 Taiho Pharmaceutical Gastric Carcinomas Drugs Introduction

11.7.4 Taiho Pharmaceutical Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.7.5 Taiho Pharmaceutical Recent Development

11.8 Jiangsu Hengrui Medicine Company Limited

11.8.1 Jiangsu Hengrui Medicine Company Limited Company Details

11.8.2 Jiangsu Hengrui Medicine Company Limited Business Overview

11.8.3 Jiangsu Hengrui Medicine Company Limited Gastric Carcinomas Drugs Introduction

11.8.4 Jiangsu Hengrui Medicine Company Limited Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.8.5 Jiangsu Hengrui Medicine Company Limited Recent Development

11.9 Fujian Haiwang Fuyao Pharmacy Limited Company

11.9.1 Fujian Haiwang Fuyao Pharmacy Limited Company Company Details

11.9.2 Fujian Haiwang Fuyao Pharmacy Limited Company Business Overview

11.9.3 Fujian Haiwang Fuyao Pharmacy Limited Company Gastric Carcinomas Drugs Introduction

11.9.4 Fujian Haiwang Fuyao Pharmacy Limited Company Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.9.5 Fujian Haiwang Fuyao Pharmacy Limited Company Recent Development

11.10 Qilu Pharma

11.10.1 Qilu Pharma Company Details

11.10.2 Qilu Pharma Business Overview

11.10.3 Qilu Pharma Gastric Carcinomas Drugs Introduction

11.10.4 Qilu Pharma Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.10.5 Qilu Pharma Recent Development

11.11 Shandong New Era Hotel Pharmaceutical Industry Limited Company

11.11.1 Shandong New Era Hotel Pharmaceutical Industry Limited Company Company Details

11.11.2 Shandong New Era Hotel Pharmaceutical Industry Limited Company Business Overview

11.11.3 Shandong New Era Hotel Pharmaceutical Industry Limited Company Gastric Carcinomas Drugs Introduction

11.11.4 Shandong New Era Hotel Pharmaceutical Industry Limited Company Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.11.5 Shandong New Era Hotel Pharmaceutical Industry Limited Company Recent Development

11.12 Chiatai Tianqing

11.12.1 Chiatai Tianqing Company Details

11.12.2 Chiatai Tianqing Business Overview

11.12.3 Chiatai Tianqing Gastric Carcinomas Drugs Introduction

11.12.4 Chiatai Tianqing Revenue in Gastric Carcinomas Drugs Business (2020-2025)

11.12.5 Chiatai Tianqing Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Novo Nordisk

Bayer

Merck

Roche

Eli Lilly and Company

Taiho Pharmaceutical

Jiangsu Hengrui Medicine Company Limited

Fujian Haiwang Fuyao Pharmacy Limited Company

Qilu Pharma

Shandong New Era Hotel Pharmaceutical Industry Limited Company

Chiatai Tianqing

List of Tables

Table 1. Global Gastric Carcinomas Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of First Line Treatment

Table 3. Key Players of Second Line Treatment

Table 4. Key Players of Three Line Treatment

Table 5. Global Gastric Carcinomas Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gastric Carcinomas Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Gastric Carcinomas Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Gastric Carcinomas Drugs Market Share by Region (2020-2025)

Table 9. Global Gastric Carcinomas Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Gastric Carcinomas Drugs Market Share by Region (2026-2031)

Table 11. Gastric Carcinomas Drugs Market Trends

Table 12. Gastric Carcinomas Drugs Market Drivers

Table 13. Gastric Carcinomas Drugs Market Challenges

Table 14. Gastric Carcinomas Drugs Market Restraints

Table 15. Global Gastric Carcinomas Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Gastric Carcinomas Drugs Market Share by Players (2020-2025)

Table 17. Global Top Gastric Carcinomas Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Carcinomas Drugs as of 2024)

Table 18. Ranking of Global Top Gastric Carcinomas Drugs Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Gastric Carcinomas Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Gastric Carcinomas Drugs, Headquarters and Area Served

Table 21. Global Key Players of Gastric Carcinomas Drugs, Product and Application

Table 22. Global Key Players of Gastric Carcinomas Drugs, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gastric Carcinomas Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Gastric Carcinomas Drugs Revenue Market Share by Type (2020-2025)

Table 26. Global Gastric Carcinomas Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Gastric Carcinomas Drugs Revenue Market Share by Type (2026-2031)

Table 28. Global Gastric Carcinomas Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Gastric Carcinomas Drugs Revenue Market Share by Application (2020-2025)

Table 30. Global Gastric Carcinomas Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Gastric Carcinomas Drugs Revenue Market Share by Application (2026-2031)

Table 32. North America Gastric Carcinomas Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Gastric Carcinomas Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Gastric Carcinomas Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Gastric Carcinomas Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Gastric Carcinomas Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Gastric Carcinomas Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Gastric Carcinomas Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Gastric Carcinomas Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Gastric Carcinomas Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Gastric Carcinomas Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Gastric Carcinomas Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Gastric Carcinomas Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Gastric Carcinomas Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Gastric Carcinomas Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Gastric Carcinomas Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pfizer Company Details

Table 48. Pfizer Business Overview

Table 49. Pfizer Gastric Carcinomas Drugs Product

Table 50. Pfizer Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 51. Pfizer Recent Development

Table 52. Novo Nordisk Company Details

Table 53. Novo Nordisk Business Overview

Table 54. Novo Nordisk Gastric Carcinomas Drugs Product

Table 55. Novo Nordisk Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 56. Novo Nordisk Recent Development

Table 57. Bayer Company Details

Table 58. Bayer Business Overview

Table 59. Bayer Gastric Carcinomas Drugs Product

Table 60. Bayer Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 61. Bayer Recent Development

Table 62. Merck & Co Company Details

Table 63. Merck & Co Business Overview

Table 64. Merck & Co Gastric Carcinomas Drugs Product

Table 65. Merck & Co Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 66. Merck & Co Recent Development

Table 67. Roche Company Details

Table 68. Roche Business Overview

Table 69. Roche Gastric Carcinomas Drugs Product

Table 70. Roche Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 71. Roche Recent Development

Table 72. Eli Lilly and Company Company Details

Table 73. Eli Lilly and Company Business Overview

Table 74. Eli Lilly and Company Gastric Carcinomas Drugs Product

Table 75. Eli Lilly and Company Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 76. Eli Lilly and Company Recent Development

Table 77. Taiho Pharmaceutical Company Details

Table 78. Taiho Pharmaceutical Business Overview

Table 79. Taiho Pharmaceutical Gastric Carcinomas Drugs Product

Table 80. Taiho Pharmaceutical Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 81. Taiho Pharmaceutical Recent Development

Table 82. Jiangsu Hengrui Medicine Company Limited Company Details

Table 83. Jiangsu Hengrui Medicine Company Limited Business Overview

Table 84. Jiangsu Hengrui Medicine Company Limited Gastric Carcinomas Drugs Product

Table 85. Jiangsu Hengrui Medicine Company Limited Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 86. Jiangsu Hengrui Medicine Company Limited Recent Development

Table 87. Fujian Haiwang Fuyao Pharmacy Limited Company Company Details

Table 88. Fujian Haiwang Fuyao Pharmacy Limited Company Business Overview

Table 89. Fujian Haiwang Fuyao Pharmacy Limited Company Gastric Carcinomas Drugs Product

Table 90. Fujian Haiwang Fuyao Pharmacy Limited Company Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 91. Fujian Haiwang Fuyao Pharmacy Limited Company Recent Development

Table 92. Qilu Pharma Company Details

Table 93. Qilu Pharma Business Overview

Table 94. Qilu Pharma Gastric Carcinomas Drugs Product

Table 95. Qilu Pharma Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 96. Qilu Pharma Recent Development

Table 97. Shandong New Era Hotel Pharmaceutical Industry Limited Company Company Details

Table 98. Shandong New Era Hotel Pharmaceutical Industry Limited Company Business Overview

Table 99. Shandong New Era Hotel Pharmaceutical Industry Limited Company Gastric Carcinomas Drugs Product

Table 100. Shandong New Era Hotel Pharmaceutical Industry Limited Company Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 101. Shandong New Era Hotel Pharmaceutical Industry Limited Company Recent Development

Table 102. Chiatai Tianqing Company Details

Table 103. Chiatai Tianqing Business Overview

Table 104. Chiatai Tianqing Gastric Carcinomas Drugs Product

Table 105. Chiatai Tianqing Revenue in Gastric Carcinomas Drugs Business (2020-2025) & (US$ Million)

Table 106. Chiatai Tianqing Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Gastric Carcinomas Drugs Picture

Figure 2. Global Gastric Carcinomas Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gastric Carcinomas Drugs Market Share by Type: 2024 VS 2031

Figure 4. First Line Treatment Features

Figure 5. Second Line Treatment Features

Figure 6. Three Line Treatment Features

Figure 7. Global Gastric Carcinomas Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Gastric Carcinomas Drugs Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Others Case Studies

Figure 12. Gastric Carcinomas Drugs Report Years Considered

Figure 13. Global Gastric Carcinomas Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Gastric Carcinomas Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Gastric Carcinomas Drugs Market Share by Region: 2024 VS 2031

Figure 16. Global Gastric Carcinomas Drugs Market Share by Players in 2024

Figure 17. Global Top Gastric Carcinomas Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastric Carcinomas Drugs as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Gastric Carcinomas Drugs Revenue in 2024

Figure 19. North America Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Gastric Carcinomas Drugs Market Share by Country (2020-2031)

Figure 21. United States Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Gastric Carcinomas Drugs Market Share by Country (2020-2031)

Figure 25. Germany Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Gastric Carcinomas Drugs Market Share by Region (2020-2031)

Figure 33. China Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Gastric Carcinomas Drugs Market Share by Country (2020-2031)

Figure 41. Mexico Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Gastric Carcinomas Drugs Market Share by Country (2020-2031)

Figure 45. Turkey Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Gastric Carcinomas Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 49. Novo Nordisk Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 50. Bayer Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 51. Merck & Co Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 53. Eli Lilly and Company Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 54. Taiho Pharmaceutical Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 55. Jiangsu Hengrui Medicine Company Limited Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 56. Fujian Haiwang Fuyao Pharmacy Limited Company Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 57. Qilu Pharma Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 58. Shandong New Era Hotel Pharmaceutical Industry Limited Company Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 59. Chiatai Tianqing Revenue Growth Rate in Gastric Carcinomas Drugs Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gastric Cancer Drugs Market Research Report 2024

Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Cancer and Gastric Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gastric Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stomach Cancer Drugs Market Insights Forecast to 2030

Cancer Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gynecological Cancers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

NSCLC Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Cancer and Gastric Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Skin Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stomach Cancer Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stomach Cancer Molecular Diagnostics Market Research Report 2024

Testicular Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Children Stomach Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Targeted Drugs for Colorectal Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bladder Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Gastritis Drugs Market Research Report 2024

Antiemetics for Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastric Antisecretory Drug Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions